Achieve life sciences to host smoking cessation key opinion leader virtual roundtable on november 17th, 2020

Seattle and vancouver, bc, oct. 27, 2020 /prnewswire/ --achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the company...

ACHV Ratings Summary

ACHV Quant Ranking